Gain of function mutations in p53 (original) (raw)
References
Johnson, P. & Benchimol, S. Friend virus induced murine erythroleukaemia: The p53 locus, in Cancer Surveys12, (ed. A.J. Levine) 137–151 (Cold Spring Harbor Press, New York, 1992). Google Scholar
Baker, S.J. et al. Chromosome 17 deletions and p53 gene mutations in colorectal carcinoma. Science244, 217–221 (1989). ArticleCAS Google Scholar
Baker, S.J., Markowitz, S., Fearon, E.R., Willson, J.K.U. & Vogelstein, B. Suppression of human colorectal carcinoma cell growth by wild-type p53. Science249, 912–915 (1990). ArticleCAS Google Scholar
Finlay, C.A., Hinds, P.W. & Levine, A.J. The p53 proto-oncogene can act as a suppressor of transformation. Cell57, 1083–1093 (1989). ArticleCAS Google Scholar
Chen, P.-L., Chen, Y., Bookstein, R. & Lee, W.-H. Genetic mechanisms of tumour suppression by the human p53 gene. Science250, 1576–1579 (1990). ArticleCAS Google Scholar
Farmer, G.E. et al. Wild-type p53 activates transcription in vitro. Nature358, 83–86 (1992). ArticleCAS Google Scholar
Kern, S. et al. Oncogenic forms of p53 inhibit p53-regulated gene expression. Science256, 827–32 (1992). ArticleCAS Google Scholar
Zambetti, G.P., Bargonetti, J., Walker, K., Prives, C. & Levine, A.J. Wild-type p53 mediates positive regulation of gene expression through a specific DNA sequence element. Genes Dev.6, 1143–1152 (1992). ArticleCAS Google Scholar
Bargonetti, J., Friedman, P.N., Kern, S.E., Vogelstein, B. & Prives, C. Wild-type but not mutant p53 immunopurified proteins bind to sequences adjacent to the SV40 origin of replication. Cell65, 1083–1091 (1991). ArticleCAS Google Scholar
El-Deiry, W.S., Kern, S.E., Pietenpol, J.A., Kinzler, K.W. & Vogelstein, B. Definition of a consensus binding site for p53. Nature Genet.1, 45–49 (1992). ArticleCAS Google Scholar
Funk, W.D. et al. A transcriptionally active DNA-binding site for human p53 protein complexes. Molec. cell. Biol.12, 2866–2871 (1992). ArticleCAS Google Scholar
Kern, S.E. et al. Identification of p53 as a sequence-specific DNA-binding protein. Science252, 1708–1711 (1991). ArticleCAS Google Scholar
Barnonetti, J. et al. Site-specific binding of wild-type p53 to cellular DMA is inhibited by SV40 T antigen and mutant p53. Genes Dev.6, 1886–1898 (1992). Article Google Scholar
Levine, A.J., Momand, J. & Finlay, C.A. The p53 tumour suppressor gene. Nature351, 453–456 (1991). ArticleCAS Google Scholar
Hollstein, M., Sidransky, D., Vogelstein, B. & Harris, C.C. p53 mutations in human cancers. Science253, 49–53 (1991). ArticleCAS Google Scholar
Kern, S.E. et al. Mutant p53 proteins bind DNA abnormally in vitro. Oncogene6, 131–136 (1991). CAS Google Scholar
Mietz, J.A., Unger, T., Huibregtse, J.M. & Howley, P.M. The transcriptional transactivation function of wild-type p53 is inhibited by SV40 large T-antigen and by HPV-16 E6 oncoprotein. EMBO J.11, 5013–5020 (1992). ArticleCAS Google Scholar
Yew, P.R. & Berk, A.J. Inhibition of p53 transactivat ion required for transformation by adenovirus E1B 55 Kd protein. Nature357, 82–85 (1992). ArticleCAS Google Scholar
Momand, J., Zambetti, G.P., Olson, D.C., George, D. & Levine, A.J. The mdm-2 oncogene product forms a complex with the p53 protein and inhibits p53 mediated transactivation. Cell69, 1237–1245 (1992). ArticleCAS Google Scholar
Zambetti, G.P., Olson, D., Labow, M. & Levine, A.J. A mutant p53 protein is required for the maintenance of the transformed cell phenotype in p53 plus ras transformed cells. Proc. natn. Acad. Sci. U.S.A.89, 3952–3956 (1992). ArticleCAS Google Scholar
Martinez, J., Georgoff, I., Martinez, J. & Levine, A.J. Cellular localization and cell cycle regulation by a temperature sensitive p53 protein. Genes Dev.5, 151–159 (1991). ArticleCAS Google Scholar
Eliyahu, D., Raz, A., Gruss, P., Givol, D. & Oren, M. Participation of p53 cellular tumour antigen in transformation of normal embryonic cells. Nature312, 646–649 (1984). ArticleCAS Google Scholar
Parada, L.F., Land, H., Weinberg, R.A., Wolf, D. & Rotter, V. Cooperation between gene encoding p53 tumour antigen and ras in cellular transformation. Nature312, 649–651 (1984). ArticleCAS Google Scholar
Jenkins, J.R., Rudge, K. & Currie, G.A. Cellular immortalization by a cDNA clone encoding the transformation–associated phosphoprotein p53. Nature312, 651–654 (1984). ArticleCAS Google Scholar
Wolf, D., Admon, S., Oren, M. & Rotter, V. Abelson murine leukemia virus-transformed cells that lack p53 protein synthesis express aberrant p53 mRNA species. Molec. cell. Biol.4, 552–558 (1984). ArticleCAS Google Scholar
Shaulsky, G., Goldfinger, N. & Rotter, V. Alterations in tumour development in vivo mediated by expression of wild-type or mutant p53 proteins. Cancer Res.51, 5232–5237 (1991). CASPubMed Google Scholar
Harvey, D. & Levine, A.J. p53 alteration is a common event in the spontaneous immortalization of primary BALB/C murine embryo fibroblasts. Genes Dev.5, 2375–2385 (1991). ArticleCAS Google Scholar
Masuda, H., Miller, C., Koeffler, H.P., Battifora, H. & Cline, M.J. Rearrangement of the p53 gene in human osteogenic sarcomas. Proc. natn. Acad. Sci. U.S.A.84, 7716–7719 (1987). ArticleCAS Google Scholar
Hinds, P.W. et al. Mutant p53 cDNAs from human colorectal carcinomas can cooperate with ras in transformation of primary rat cells: A comparison of the “hot spot” mutant phenotypes. Cell Growth Diff.1, 571–580 (1990). CAS Google Scholar
Baker, S.J., Markowitz, S., Fearon, E.R., Willson, J.K.U. & Vogelstein, B. Suppression of human colorectal carcinoma cell growth by wild-type p53. Science249, 912–915 (1990). ArticleCAS Google Scholar
Diller, L. et al. p53 functions as a cell cycle control protein in osteosarcomas. Molec. cell. Biol.10, 5772–5781 (1990). ArticleCAS Google Scholar
Johnson, P., Gray, D., Mowat, M. & Benchimol, S. Expression of wild-type p53 is not compatible with continued growth of p53-negative tumour cells. Molec. cell. Biol.11, 1–11 (1991). ArticleCAS Google Scholar
Mercer, W.E. et al. Negative growth regulation in a glioblastoma tumour cell line that conditionally expresses human wild-type p53. Proc. natn. Acad. Sci. U.S.A.87, 6166–6170 (1990). ArticleCAS Google Scholar
Eliyahu, D., Michalovitz, D. & Oren, M. Overproduction of p53 antigen makes established cells highly tumorigenic. Nature316, 158–160 (1985). ArticleCAS Google Scholar
Chin, K.V., Ueda, K., Pastan, I. & Gottesman, M.M. Modulation of activity of the promoter of the human MDR1 gene by ras and p53. Science, 255, 459–462 (1992). ArticleCAS Google Scholar
Werness, B.A., Levine, A.J. & Howley, P.M. Association of human papillomavirus types 16 and 18 E6 proteins with p53. Science248, 76–79 (1990). ArticleCAS Google Scholar
Scheffner, M., Werness, B.A., Huibregtse, J.M., Levine, A.J. & Howley, P.M. The E6 oncoprotein encoded by human papillomavirus 16 or 18 promotes the degradation of p53. Cell63, 1129–1136 (1990). ArticleCAS Google Scholar
Riou, G. et al. Association between poor prognosis in early stage invasive cervical carcinomas and nondetection of HPV DNA. Lancet335, 1171–1174 (1990). ArticleCAS Google Scholar
Tan, T.-H., Wallis, J. & Levine, A.J. Identification of the p53 protein domain involved in formation of the simian virus 40 large T antigen-p53 protein complex. J. Virol.59, 574–583 (1986). CASPubMedPubMed Central Google Scholar
Reich, N.C. & Levine, A.J. Growth regulation of a cellular tumour antigen, p53, in nontransformed cells. Nature308, 199–201 (1984). ArticleCAS Google Scholar
Thor, A.D. et al. Accumulation of p53 tumour suppressor gene protein: an independent marker of prognosis in breast cancer. J. natn. Cancer Inst.84, 845–855 (1992). ArticleCAS Google Scholar
Martin, H.M., Filipe, M.I., Morris, R.W., Lane, D.P. & Silvestre, F. p53 expression and prognosis in gastric carcinoma. Int. J. Cancer50, 859–862 (1992). ArticleCAS Google Scholar